Medicine and Dentistry
Liver Disease
100%
Alcohol-Related Liver Disease
96%
Liver Fibrosis
94%
Liver Cirrhosis
91%
Fibrosis
81%
Nonalcoholic Fatty Liver
60%
Fatty Liver
42%
Diseases
38%
Biological Marker
33%
Transient Elastography
33%
Chronic Liver Disease
31%
Bleeding
25%
Alcohol Consumption
25%
Portal Hypertension
25%
Elastography
25%
Alcohol Liver Disease
23%
Primary Health Care
23%
Liver Biopsy
22%
Acute on Chronic Liver Failure
20%
Biopsy Technique
20%
Steatosis
19%
Shear Wave Elastography
19%
Meta-Analysis
19%
Transjugular Intrahepatic Portosystemic Shunt
19%
Non-Alcoholic Fatty Liver Disease
18%
Steatohepatitis
17%
Decompensated Liver Cirrhosis
17%
Patient-Data
16%
Alpha 1-Antitrypsin Deficiency
16%
Patient Referral
15%
Ascites
15%
Diagnostic Accuracy
14%
Gut
14%
Hepatic Encephalopathy
13%
Rifaximin
13%
Public Health
12%
Body Mass Index
12%
Infection
11%
Randomized Controlled Trial
11%
Prospective Cohort Study
11%
Prevalence
11%
Disease Severity
10%
Microbiome
10%
Clinical Trial
10%
Gut Microbiome
10%
Cost-Effectiveness Analysis
9%
Liver Transplantation
9%
Cardiovascular Disease
8%
Liver Injury
8%
Bacterial Infection
8%
Health Care Cost
8%
Fibrogenesis
8%
Collagen Type 3
8%
Metabolic Dysfunction-Associated Steatotic Liver Disease
8%
Cohort Analysis
8%
Hazard Ratio
8%
Hepatocellular Carcinoma
8%
Prognostication
7%
Triacylglycerol
7%
Secondary Care
7%
Randomized Clinical Trial
7%
Platelet
7%
Hepatic Stellate Cell
7%
Aspartate Aminotransferase
7%
Alanine Aminotransferase
7%
Focused Ion Beam
7%
Liver Cancer
6%
Risk Stratification
6%
High Fat Food
6%
Disease Management
6%
Acute Liver Failure
6%
Early Diagnosis
6%
Placebo
6%
Spontaneous Portosystemic Shunt
6%
Binge Drinking
6%
Extracellular Matrix
6%
Alpha 1 Antitrypsin
6%
Cohort Effect
6%
Tamsulosin
5%
Endoscopy
5%
Comorbidity
5%
Decision Making
5%
False Positive Result
5%
Disease Burden
5%
Alcohol Intoxication
5%
Hepatology
5%
Maturity Onset Diabetes of the Young
5%
Odds Ratio
5%
All Cause Mortality
5%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Disease
62%
Fibrosis
40%
Liver Fibrosis
35%
Liver Cirrhosis
33%
Nonalcoholic Fatty Liver
25%
Inflammation
22%
Biological Marker
17%
Diseases
17%
Fatty Liver
13%
Acute on Chronic Liver Failure
12%
Disease Activity
10%
Chronic Liver Disease
9%
Steatosis
9%
Bleeding
8%
Bacterial Infection
8%
Alcohol Liver Disease
8%
Portal Hypertension
7%
Collagen Type 3
6%
Randomized Controlled Trial
6%
Liver Injury
6%
Terlipressin
6%
Disease Severity
6%
Randomized Clinical Trial
6%
Clinical Trial
5%
Ascites
5%
Albumin
5%
Decompensated Liver Cirrhosis
5%
Biochemistry, Genetics and Molecular Biology
Rigidity
27%
Alpha 1-Antitrypsin
16%
Blood Plasma
13%
Prevalence
11%
Body Mass
9%
Patient Coding
9%
Basement Membrane
9%
Triglyceride
9%
Lipid
9%
Fibrogenesis
9%
Enzyme
7%
Genetic Risk
7%
Genotyping
7%
Hepatic Stellate Cell
7%
Proteomics
6%
Tamsulosin
6%
Aspartate Transaminase
6%
Lipid Liver Level
5%
Sphingomyelin
5%
Lipid Storage
5%